摘要
长期的、前瞻性的流行病学研究表明,预防和合理处理血脂异常可以改变心血管疾病和中风的发病率和病死率。动脉粥样硬化是一种全身性疾病,其特征是动脉内膜散在的斑块形成,现有治疗动脉粥样硬化的药物如降脂药、抗凝药、溶栓药效果单一且都是对症治疗,因而不够理想。而在中医学"病证结合""辨证论治""整体观念"的指导下,中医药治疗血脂异常、动脉粥样硬化具有多靶点、多环节、多途径的优势。开展中医药综合方案进行干预人群的临床干预及生物学机制研究,可以明确中医"治未病"干预技术方案及切入时点,降低疾病风险。本文就中医对血脂异常、动脉粥样硬化的认识作一简要论述。
Long term and prospective epidemiological studies have shown that prevention and treatment of dyslipidemia can alter the incidence rate and mortality of cardiovascular diseases and strokes. Atherosclerosis is a systemic disease, which is characterized by the formation of scattered plaque in the intima of arteries. The existing drugs for the treatment of atherosclerosis, such as lipid-lowering drugs, anticoagulants and thrombolytic drugs, have single effect and are symptomatic treatment, so they are not ideal. Under the guidance of "combination of disease and syndrome", "syndrome dif ferentiation and treatment" and "holistic concept", TCM has the advantages of multitarget, multi-link and multi-channel in the treatment of dyslipidemia and atherosclerosis. To carry out the research on clinical intervention and biological mechanism of the intervention population with comprehensive program of traditional Chinese medicine can make clear the intervention technical scheme and breakthrough point of "preventive treatment of disease" of traditional Chinese medicine, and reduce the risk of disease. This paper briefly discusses the understanding of dyslipidemia and atherosclerosis in TCM.
作者
姚璠
王莹
冷向阳
赵为民
YAO Fan;WANG Ying;LENG Xiangyang;ZHAO Weimin(Changchun University of Chinese Medicine,Changchun 130117,China)
出处
《吉林中医药》
2020年第10期1282-1285,共4页
Jilin Journal of Chinese Medicine
基金
国家重点研发计划(2018YFC1704702)
吉林省卫健委(2018Q045)
吉林省中医药管理局(2019092)。
关键词
血脂异常
动脉粥样硬化
中医药研究进展
治未病
dyslipidemia
atherosclerosis
research progress of traditional Chinese medicine
intervention for treatment of non-disease
